Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Ik zie het niet in mijn trader dus kan sowieso niet mee doen. Maarja, je kunt als je goed gokt wel een xtje de 50% pakken.
Al fase 3 stamcel en aandeel is nog geen 5 cent waard. Dit zou hoger moeten staan dan Tigenix. investorshub.advfn.com/US-Stem-Cell-I...
Ik heb op het gebied van Biotech niet zo veel verstand maar het lijkt me een extreem ondergewaard aandeel wat een overname kandidaat is. Ik dacht hier op het Tigenix forum zitten wel wat kenners. Hier hun website kan je de clinical trials zien. us-stemcell.com/en/clinical-trials/
TheBateman schreef op 1 maart 2017 12:13 :
Ik zie het niet in mijn trader dus kan sowieso niet mee doen. Maarja, je kunt als je goed gokt wel een xtje de 50% pakken.
Het is op de Amerikaanse beurs genoteerd.
t’s a fool’s trade. Or rather, we should say, it was. After infuriating investors with bankruptcy filings and crumbling valuations for years, stem cell companies have been crushed. Many suffered delays, burning through cash with few results. StemCells – now Microbot Medical (MBOT) -- fell from a $228 high in 2014 to less than $4 this year. International Stem Cell Corporation (ISCO) fell from $56 to $1.10. S. Stem Cell (USRM) fell from $80 to less than a penny. Vericel Corporation (VCEL) (formerly Aastrom Biosciences) fell from $55 to $2.50, but is beginning to show signs of life at its lows. Geron Corporation (GERN), which was responsible for the first human trial to use cells from human embryonic stem cells. Unfortunately, the trial was halted on concerns of purity and predictability of implanted cells, and again after the company report seeing microscopic cysts in the spinal cords of rats. It’s been a disaster for investors. Some would say it’s not worth the investment. But we beg to differ. Just look at recent mergers and acquisitions. Thermo Fisher (TMO) just bought MTI-GlobalStem, which provides neural, stem and supporting feeder cells. In April 2016, Thermo Fisher acquired Affymetrix, which provides cellular and genetic analysis, tools needed for stem cell research. AbbVie (ABBV) bought Stemcentryx for $5.8 billion, helping it add several stem cell cancer therapies to its pipeline. Fujifilm (FUJIY) acquired Cellular Dynamics International. Smart investors are actually being handed the opportunity of a lifetime at such lows, as stem cell companies look to treat stokes, traumatic brain injury, Alzheimer’s, Parkinson’s, wound healing, osteo- and rheumatoid-arthritis, diabetes and cancer just to name a few… It’s exciting… and could be wildly profitable for smart investors. Researchers from University College London found that stem cells found in human amniotic fluid could be used to strengthen brittle bones, for example. Published research showed 79% fewer bone fractures in mice with brittle bone disease. Out of 324 mice, 168 were treated with 156 in the control group. Each control mouse had fractures. However, in the experimental group, fractures decreased between 69% and 89%, leading to a 79% decrease in the fracture rates across all test subjects. There’s hope is that this can be replicated in humans, and help those that suffer from things such as osteoporosis. Brittle bone disease affects up to 50,000 people in the U.S. alone. Or, look at regenerative treatments for heart disease. In the U.S. and Europe alone, about two million people suffer from heart attacks, which can lead to congestive and chronic heart failure that has no cure other than transplantation. In the U.S., it costs $30 billion to treat heart failure yearly. That’s expected to soar to $70 billion by 2030. But cell companies could help there, too. In fact, Capricor Therapeutics’ lead candidate CAP-1002 is being tested for safety and effectiveness in impacting heart function, and its ability to decrease scar tissue and promoting growth of heart muscle, which could prevent heart failure. At the moment, a number of approved medications are used to treat chronic heart failure, but none change dysfunctional cardiac structure, as Capricor is trying to do. Other than heart disease, several other companies will have late-stage stem cell results in the next few quarters, as well or Pediatric Graft vs host disease (GVHD), rheumatoid arthritis, scleroderma, and even severe sepsis. Granted, the past hasn’t been kind to stem cells. But we’re entering a phase of incredible growth potential again. Look at BioTime (BTX), which is now it Phase 1/2a clinical trials in patients with complete cervical spinal cord injury, for example. Considering 1.3 million Americans with this injury have no approved therapies or devices to help, this would be a substantial unmet medical need. Worse, the cost of care for an individual averages $3 to $4 million over a person’s lifetime. Clearly, there’s demand for such therapy. Globally, the market was valued at $37.88 billion in 2013, expected to hit $170.15 billion by 2020 on the heels of increasing research and development and big funding by government for drug discovery and development for unmet medical needs. Many of these stem cell companies are still good buys. Many are trading at incredible discounts with favorable developments. We understand there’s always risk in stem cell companies. But for risk-tolerant smart investors, such investments hold a great deal of long-term opportunity. We just recently recommended a trade in Stealth Stock Trader that is showing solid fundamental strength. Stay tuned for more.
Na beurs weer 75% er af. Succes
Hettie schreef op 1 maart 2017 14:05 :
Na beurs weer 75% er af. Succes
nee hoor Hettie zoiets heet T trade incrediblepennystocks.wordpress.com/2...
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
872,63
+0,71%
EUR/USD
1,0670
+0,17%
FTSE 100
8.025,04
+0,01%
Germany40^
18.057,90
+1,10%
Gold spot
2.312,11
-0,65%
NY-Nasdaq Composite
15.451,31
+1,11%
Stijgers
Dalers